| 臺大學術典藏 |
2018-09-10T07:30:29Z |
Inference on treatment effects for targeted clinical trials under enrichment design
|
Liu, J.-P.;Lin Jr.;R.;Chow, S.-C.; Liu, J.-P.; Lin Jr.; R.; Chow, S.-C.; JEN-PEI LIU |
| 臺大學術典藏 |
2018-09-10T07:30:29Z |
Botulinum toxin (Dysport) treatment of the spastic gastrocnemius muscle in children with cerebral palsy: A randomized trial comparing two injection volumes
|
Hu, G.-C.;Chuang, Y.-C.;Liu, J.-P.;Chien, K.-L.;Chen, Y.-M.;Chen, Y.-F.; Hu, G.-C.; Chuang, Y.-C.; Liu, J.-P.; Chien, K.-L.; Chen, Y.-M.; Chen, Y.-F.; JEN-PEI LIU; KUO-LIONG CHIEN |
| 臺大學術典藏 |
2018-09-10T07:30:29Z |
A noninferiority test for treatment-by-factor interaction with application to bridging studies and global trials
|
Liu, J.-P. and Lin Jr., R. and Hsieh, E.; JEN-PEI LIU |
| 臺大學術典藏 |
2018-09-10T07:30:29Z |
Statistical evaluations of dissolution similarity
|
Jen-Pei Liu; JEN-PEI LIU |
| 臺大學術典藏 |
2018-09-10T07:30:29Z |
Statistical evaluations of dissolution similarity
|
Jen-Pei Liu; JEN-PEI LIU |
| 臺大學術典藏 |
2018-09-10T07:30:28Z |
Statistical validation of traditional Chinese diagnostic procedures
|
Hsiao, C.-F. and Tsou, H.-H. and Pong, A. and Liu, J.-P. and Lin, C.-H. and Chang, Y.-J. and Chow, S.-C.; JEN-PEI LIU |
| 臺大學術典藏 |
2018-09-10T07:30:28Z |
Statistical methods for evaluating the linearity in assay validation
|
Hsieh, E.;Hsiao, C.-F.;Liu, J.-P.; Hsieh, E.; Hsiao, C.-F.; Liu, J.-P.; JEN-PEI LIU |
| 臺大學術典藏 |
2018-09-10T07:29:04Z |
Statistical inference for the within-device precision of quantitative measurements in assay validation
|
CHEN-TUO LIAO; JEN-PEI LIU; Liao, C.T.; Lu, L.-T.; Liu, J.-P.; Liu, J.-P.;Lu, L.-T.;Liao, C.T. |
| 臺大學術典藏 |
2018-09-10T06:57:53Z |
Design and Analysis of Animal Studies in Pharmaceutical Development
|
Jen-Pei Liu; JEN-PEI LIU; JEN-PEI LIU |
| 臺大學術典藏 |
2018-09-10T06:57:53Z |
Design and Analysis of Animal Studies in Pharmaceutical Development
|
Jen-Pei Liu; JEN-PEI LIU; JEN-PEI LIU |
| 臺大學術典藏 |
2018-09-10T06:57:53Z |
Design and Analysis of Animal Studies in Pharmaceutical Development
|
Jen-Pei Liu; JEN-PEI LIU; JEN-PEI LIU |
| 臺大學術典藏 |
2018-09-10T06:57:52Z |
The integrated clinical and statistical report for registration in Taiwan
|
Jen-Pei Liu; JEN-PEI LIU |
| 臺大學術典藏 |
2018-09-10T06:57:52Z |
The integrated clinical and statistical report for registration in Taiwan
|
Jen-Pei Liu; JEN-PEI LIU |
| 臺大學術典藏 |
2018-09-10T06:57:52Z |
Statistical evaluation of individual bioequivalence
|
Jen-Pei Liu; JEN-PEI LIU |
| 臺大學術典藏 |
2018-09-10T06:57:52Z |
Statistical evaluation of individual bioequivalence
|
Jen-Pei Liu; JEN-PEI LIU |
| 臺大學術典藏 |
2018-09-10T06:57:52Z |
In vitro dissolution profile comparison- Statistics and analysis of the similarity factor, f2
|
Shah, V.P.; Tsong, Y.; Sathe, P.; Liu, J.-P.; Shah, V.P.; Tsong, Y.; Sathe, P.; Liu, J.-P.; JEN-PEI LIU |
| 臺大學術典藏 |
2018-09-10T06:57:52Z |
Design and Analysis of Bioavailability and Bioequivalence, third edition
|
JEN-PEI LIU; JEN-PEI LIU; JEN-PEI LIU |
| 臺大學術典藏 |
2018-09-10T06:57:52Z |
Design and Analysis of Bioavailability and Bioequivalence, third edition
|
JEN-PEI LIU; JEN-PEI LIU; JEN-PEI LIU |
| 臺大學術典藏 |
2018-09-10T06:57:52Z |
Design and Analysis of Bioavailability and Bioequivalence, third edition
|
JEN-PEI LIU; JEN-PEI LIU; JEN-PEI LIU |
| 臺大學術典藏 |
2018-09-10T06:57:52Z |
Design and Analysis of Clinical Trials: Concepts and Methodologies
|
Jen-Pei Liu; JEN-PEI LIU; JEN-PEI LIU |
| 臺大學術典藏 |
2018-09-10T06:57:52Z |
Design and Analysis of Clinical Trials: Concepts and Methodologies
|
Jen-Pei Liu; JEN-PEI LIU; JEN-PEI LIU |
| 臺大學術典藏 |
2018-09-10T06:57:52Z |
Design and Analysis of Clinical Trials: Concepts and Methodologies
|
Jen-Pei Liu; JEN-PEI LIU; JEN-PEI LIU |
| 臺大學術典藏 |
2018-09-10T06:57:51Z |
On statistical evaluation of the linearity in assay validation
|
Hsieh, E.;Liu, J.-P.; Hsieh, E.; Liu, J.-P.; JEN-PEI LIU |
| 臺大學術典藏 |
2018-09-10T06:57:51Z |
Commentary on "accounting for the interim safety monitoring of an adverse event upon termination of a clinical trial"
|
Liu, J.-P.; Liu, J.-P.; JEN-PEI LIU |
| 臺大學術典藏 |
2018-09-10T06:57:51Z |
A two-stage design for drug screening trials based on continuous endpoints
|
Tsou, H.-H. and Hsiao, C.-F. and Chow, S.-C. and Liu, J.-P.; JEN-PEI LIU |
